| 1 | little | 11,688 |
| 2 | huasi | 5 |
| 3 | ultrafiltration-induced | 5 |
| 4 | genifuranal | 4 |
| 5 | sympatholytic* | 4 |
| 6 | wave2-arp2/3 | 4 |
| 7 | adjusted/clustered | 3 |
| 8 | holdfast | 3 |
| 9 | palosuran | 3 |
| 10 | potorolepis | 3 |
| 11 | 'something | 2 |
| 12 | 40-bpm | 2 |
| 13 | amino-cerv | 2 |
| 14 | behavioral-risk | 2 |
| 15 | bright-white | 2 |
| 16 | embryoglue | 2 |
| 17 | epoetin-omega | 2 |
| 18 | estropipate | 2 |
| 19 | forward-lunge | 2 |
| 20 | l-propranolol- | 2 |
| 21 | micro-calcifications | 2 |
| 22 | npc1-deficiency | 2 |
| 23 | pa-wei-ti-huang-wan | 2 |
| 24 | peritonization | 2 |
| 25 | pop2 | 2 |
| 26 | safrol | 2 |
| 27 | sillok | 2 |
| 28 | tele-medicine | 2 |
| 29 | theorectical | 2 |
| 30 | touji | 2 |
| 31 | unclear.this | 2 |
| 32 | ureterocystoplasty | 2 |
| 33 | valdoxen | 2 |
| 34 | €70,180 | 2 |
| 35 | 'polymorphism | 1 |
| 36 | 'ram | 1 |
| 37 | 'tia | 1 |
| 38 | 0.024.the | 1 |
| 39 | 0.079.there | 1 |
| 40 | 1,2,4,15-configuration | 1 |
| 41 | 1,2u/l | 1 |
| 42 | 1,6-di- | 1 |
| 43 | 1-h-indole-3-glyoxamide | 1 |
| 44 | 10-15mmhg | 1 |
| 45 | 10/40- | 1 |
| 46 | 150-160°c | 1 |
| 47 | 186-rhenium | 1 |
| 48 | 19-mg | 1 |
| 49 | 1979-88 | 1 |
| 50 | 2'-arylthio-3,3'-bithiophene-2-carbaldehydes | 1 |
| 51 | 2-/5-methyl- | 1 |
| 52 | 2-cyanoacetamide | 1 |
| 53 | 2.8e-30 | 1 |
| 54 | 215.15 | 1 |
| 55 | 3-amino-isobutyrate | 1 |
| 56 | 3-succinoyl-4,5-dicaffeoyl | 1 |
| 57 | 4'-f | 1 |
| 58 | 4-oha | 1 |
| 59 | 5.22e-15 | 1 |
| 60 | 5.39°c | 1 |
| 61 | 5fu-cisplatin | 1 |
| 62 | abca3 | 1 |
| 63 | ac-devd-cmk-pretreated | 1 |
| 64 | acvr2a/acvr2b | 1 |
| 65 | adventageous | 1 |
| 66 | aedemas | 1 |
| 67 | africa-wide | 1 |
| 68 | ag110 | 1 |
| 69 | agronomists | 1 |
| 70 | alkaline- | 1 |
| 71 | all.it | 1 |
| 72 | aluminophosphates | 1 |
| 73 | amenorrhoe | 1 |
| 74 | anti-perk1/2 | 1 |
| 75 | anti-rage-antibody | 1 |
| 76 | antioedematogenic | 1 |
| 77 | antispychotic | 1 |
| 78 | aorto-profundal | 1 |
| 79 | aponea | 1 |
| 80 | arcuatum | 1 |
| 81 | arsonists | 1 |
| 82 | asdas-levels | 1 |
| 83 | assessed.discover | 1 |
| 84 | associated-directly | 1 |
| 85 | atfd1 | 1 |
| 86 | auc0-tn | 1 |
| 87 | backgroundpubic | 1 |
| 88 | balloon/stent | 1 |
| 89 | bbr3464 | 1 |
| 90 | beyoglu | 1 |
| 91 | bi-specificity | 1 |
| 92 | bio-slurry | 1 |
| 93 | breast-feeding.there | 1 |
| 94 | brief-clinician | 1 |
| 95 | ca15-3/br27-29 | 1 |
| 96 | canula | 1 |
| 97 | cd+se | 1 |
| 98 | cellular- | 1 |
| 99 | cephuroxime | 1 |
| 100 | cerumol® | 1 |
| 101 | cervical- | 1 |
| 102 | cetero | 1 |
| 103 | chictr-trc-00000029 | 1 |
| 104 | chondroitin-6-sulphate | 1 |
| 105 | ciclovía | 1 |
| 106 | cimp- | 1 |
| 107 | cisnet-erspc-plco | 1 |
| 108 | condition- | 1 |
| 109 | consumer- | 1 |
| 110 | cp-rate | 1 |
| 111 | crt/rt | 1 |
| 112 | ct-thorax | 1 |
| 113 | custom-trays | 1 |
| 114 | cycloheximide- | 1 |
| 115 | cyclophosphamide/doxorubicin/vincristine | 1 |
| 116 | cytoplasty | 1 |
| 117 | d212 | 1 |
| 118 | dcr-1 | 1 |
| 119 | definite/definite | 1 |
| 120 | deoxymannojirimycin | 1 |
| 121 | depth-of-interaction | 1 |
| 122 | discussed.meta-analysis | 1 |
| 123 | disreputed-so | 1 |
| 124 | dj-catheter | 1 |
| 125 | dsba-mdmt2 | 1 |
| 126 | early.more | 1 |
| 127 | ehe- | 1 |
| 128 | ejcs | 1 |
| 129 | electrocardiographical | 1 |
| 130 | endomorphic | 1 |
| 131 | ent- | 1 |
| 132 | entomophobia | 1 |
| 133 | epididimis | 1 |
| 134 | epigastrial | 1 |
| 135 | erythremia | 1 |
| 136 | essential.this | 1 |
| 137 | etomidate-lipuro | 1 |
| 138 | eu/dy | 1 |
| 139 | exatecan | 1 |
| 140 | excitation-coupled | 1 |
| 141 | exercise-induce | 1 |
| 142 | expensive-treatments | 1 |
| 143 | feedback/tailored | 1 |
| 144 | fibrillins | 1 |
| 145 | fl.there | 1 |
| 146 | fluoropirimidines | 1 |
| 147 | flurosemide | 1 |
| 148 | fracture- | 1 |
| 149 | fresubin®.there | 1 |
| 150 | g12c | 1 |
| 151 | g79a/f261w | 1 |
| 152 | gatiflixacin | 1 |
| 153 | gemcitabine-ifosfamide-cisplatin | 1 |
| 154 | ghia | 1 |
| 155 | glycopeptide-susceptible | 1 |
| 156 | grade3 | 1 |
| 157 | gs-π | 1 |
| 158 | gαi1 | 1 |
| 159 | gαi1-rgs12 | 1 |
| 160 | ha1a | 1 |
| 161 | hbe/β-thalassemia | 1 |
| 162 | hbv-as04 | 1 |
| 163 | hcv-infection | 1 |
| 164 | heighted | 1 |
| 165 | height²/impedance | 1 |
| 166 | hemiarthoplasty | 1 |
| 167 | hepatic-lipoprotein | 1 |
| 168 | hipokinesia | 1 |
| 169 | hospitalization* | 1 |
| 170 | hpv-6/11/16 | 1 |
| 171 | humanmilk | 1 |
| 172 | hydroquinone/arbutin | 1 |
| 173 | hypophenomena | 1 |
| 174 | i608 | 1 |
| 175 | identified.diagnosis | 1 |
| 176 | iia+iic | 1 |
| 177 | imt+rygb | 1 |
| 178 | insecticidal/acaricidal | 1 |
| 179 | intercostovertebral | 1 |
| 180 | intratechally | 1 |
| 181 | irak-1/4 | 1 |
| 182 | juzentaiho-to | 1 |
| 183 | k216a/v219a/p222a | 1 |
| 184 | la/s | 1 |
| 185 | lacking.this | 1 |
| 186 | lard1 | 1 |
| 187 | lf-omega-3 | 1 |
| 188 | lillehie-kaster | 1 |
| 189 | limited.there | 1 |
| 190 | lip-service | 1 |
| 191 | lipo-lymphedema | 1 |
| 192 | lipoplex/virus | 1 |
| 193 | lmk03 | 1 |
| 194 | local-to-local | 1 |
| 195 | low-consistency | 1 |
| 196 | lsf- | 1 |
| 197 | lys48- | 1 |
| 198 | maintained.it | 1 |
| 199 | makgome | 1 |
| 200 | mal-positions | 1 |
| 201 | mal-rotated | 1 |
| 202 | mallotoxin | 1 |
| 203 | malnet- | 1 |
| 204 | mambey | 1 |
| 205 | mandarin- | 1 |
| 206 | manno-arabinogalacturonan | 1 |
| 207 | maturate | 1 |
| 208 | md/msc | 1 |
| 209 | meatostomy | 1 |
| 210 | med15 | 1 |
| 211 | medicament.this | 1 |
| 212 | mediterranean’ | 1 |
| 213 | menstrual/reproductive | 1 |
| 214 | metaanalysis- | 1 |
| 215 | methotrexate/dmard | 1 |
| 216 | metimazole | 1 |
| 217 | mg-l-asp | 1 |
| 218 | mi/ua | 1 |
| 219 | microinsurance | 1 |
| 220 | midpotent | 1 |
| 221 | mis-directed | 1 |
| 222 | model-algorithm | 1 |
| 223 | modified- | 1 |
| 224 | monoplus® | 1 |
| 225 | monosulfated | 1 |
| 226 | multi-bioactivities | 1 |
| 227 | multi-targe | 1 |
| 228 | musicure | 1 |
| 229 | myelomenigoceles | 1 |
| 230 | mykosert | 1 |
| 231 | myopenia | 1 |
| 232 | nagging/arguing | 1 |
| 233 | needed.there | 1 |
| 234 | niitaka-yomogi | 1 |
| 235 | non-diagnosed | 1 |
| 236 | non-english- | 1 |
| 237 | non-retrieved | 1 |
| 238 | non-smoke | 1 |
| 239 | non-study-related | 1 |
| 240 | non-t-cell | 1 |
| 241 | notch1- | 1 |
| 242 | nozul-al-maa | 1 |
| 243 | ny-based | 1 |
| 244 | obfuscates | 1 |
| 245 | ondansetron/saline | 1 |
| 246 | orally- | 1 |
| 247 | ototopicals | 1 |
| 248 | out-of-class | 1 |
| 249 | overaeration | 1 |
| 250 | overnight- | 1 |
| 251 | overprogramming | 1 |
| 252 | palm- | 1 |
| 253 | paludrine | 1 |
| 254 | panic- | 1 |
| 255 | papaveretum-hyoscine | 1 |
| 256 | patient-volunteered | 1 |
| 257 | pedi-cap | 1 |
| 258 | pef-variability | 1 |
| 259 | peg-ifnα2a/rbv | 1 |
| 260 | penicillin/streptomycin | 1 |
| 261 | perchlorato | 1 |
| 262 | ph5.7-aw0.98 | 1 |
| 263 | pharmacist- | 1 |
| 264 | pifithrin-α- | 1 |
| 265 | pneumatocele | 1 |
| 266 | pneumo- | 1 |
| 267 | positioning/containment | 1 |
| 268 | post-ercc | 1 |
| 269 | post-fume | 1 |
| 270 | ppod | 1 |
| 271 | prednisone- | 1 |
| 272 | prelatent | 1 |
| 273 | prescribed-that | 1 |
| 274 | prewhitened | 1 |
| 275 | printmaking | 1 |
| 276 | pro-st | 1 |
| 277 | prolective | 1 |
| 278 | promoiety | 1 |
| 279 | proparasympathetic | 1 |
| 280 | prope | 1 |
| 281 | prorocentroids | 1 |
| 282 | proteotoxins | 1 |
| 283 | pyrimethamine-sulphadoxine | 1 |
| 284 | pyrrolidinoindolines | 1 |
| 285 | qol-form | 1 |
| 286 | quadri-therapy | 1 |
| 287 | r/k-x-x-v/p-x-x-p | 1 |
| 288 | rbr- | 1 |
| 289 | rect* | 1 |
| 290 | reeducative | 1 |
| 291 | reevacuation | 1 |
| 292 | reinstated-context | 1 |
| 293 | relapsed/progressed | 1 |
| 294 | renounced | 1 |
| 295 | rhadbomyolysis | 1 |
| 296 | rix4414+ipv | 1 |
| 297 | rs17861094 | 1 |
| 298 | sacculation | 1 |
| 299 | sangstat | 1 |
| 300 | saponinss | 1 |
| 301 | scophthalmi | 1 |
| 302 | secondary-transmission-of-resistance | 1 |
| 303 | seconday | 1 |
| 304 | self-disclosing | 1 |
| 305 | semi-bent | 1 |
| 306 | semi-conductive | 1 |
| 307 | semilateral | 1 |
| 308 | senkyu-cha-chosan | 1 |
| 309 | simulacrum | 1 |
| 310 | sinusotomy/sinectomy | 1 |
| 311 | sirna- | 1 |
| 312 | smmeox/mcm-41 | 1 |
| 313 | smooth-bounded | 1 |
| 314 | sodb-d | 1 |
| 315 | somatic-evoked | 1 |
| 316 | sono-hysterography | 1 |
| 317 | sphere- | 1 |
| 318 | square-plane | 1 |
| 319 | stop- | 1 |
| 320 | sub-pleural | 1 |
| 321 | subglobular | 1 |
| 322 | sulphinylmethyl | 1 |
| 323 | supratentorially | 1 |
| 324 | sympyomatic | 1 |
| 325 | syndrome/disorder | 1 |
| 326 | synovial- | 1 |
| 327 | taxative | 1 |
| 328 | tbuli | 1 |
| 329 | teratocarcinomas | 1 |
| 330 | testiculus | 1 |
| 331 | tetrahydropyrazinopyrimidinediones | 1 |
| 332 | thia- | 1 |
| 333 | thiazolidine-diones | 1 |
| 334 | thin-weak | 1 |
| 335 | thornhill | 1 |
| 336 | tienopyridines | 1 |
| 337 | tinidazol | 1 |
| 338 | tp- | 1 |
| 339 | treatment-that | 1 |
| 340 | trial-funded | 1 |
| 341 | triplegic | 1 |
| 342 | tumor-free-resection | 1 |
| 343 | type-ii-diabetes | 1 |
| 344 | ukall97/01 | 1 |
| 345 | umthakathi | 1 |
| 346 | un-spiked | 1 |
| 347 | unconfounded-that | 1 |
| 348 | underexpanded | 1 |
| 349 | uneconomic | 1 |
| 350 | unskillful | 1 |
| 351 | unsuccessfull | 1 |
| 352 | unsufficient | 1 |
| 353 | ureteropyelic | 1 |
| 354 | urolithasis | 1 |
| 355 | v219a/p222a | 1 |
| 356 | vasopastic | 1 |
| 357 | vgkc-complex | 1 |
| 358 | vim- | 1 |
| 359 | virally-mediated | 1 |
| 360 | wasm | 1 |
| 361 | wish-fulfillment | 1 |
| 362 | wittingly | 1 |
| 363 | yeast- | 1 |
| 364 | zomepirac | 1 |
| 365 | β-cat/armadillo | 1 |
| 366 | σ11 | 1 |
| 367 | ϰα | 1 |
| 368 | ≥2- | 1 |
| 369 | ≥6.7mg/dl | 1 |
| 1 | 'polymorphism | 1 |
| 2 | 'ram | 1 |
| 3 | 'something | 2 |
| 4 | 'tia | 1 |
| 5 | 0.024.the | 1 |
| 6 | 0.079.there | 1 |
| 7 | 1,2,4,15-configuration | 1 |
| 8 | 1,2u/l | 1 |
| 9 | 1,6-di- | 1 |
| 10 | 1-h-indole-3-glyoxamide | 1 |
| 11 | 10-15mmhg | 1 |
| 12 | 10/40- | 1 |
| 13 | 150-160°c | 1 |
| 14 | 186-rhenium | 1 |
| 15 | 19-mg | 1 |
| 16 | 1979-88 | 1 |
| 17 | 2'-arylthio-3,3'-bithiophene-2-carbaldehydes | 1 |
| 18 | 2-/5-methyl- | 1 |
| 19 | 2-cyanoacetamide | 1 |
| 20 | 2.8e-30 | 1 |
| 21 | 215.15 | 1 |
| 22 | 3-amino-isobutyrate | 1 |
| 23 | 3-succinoyl-4,5-dicaffeoyl | 1 |
| 24 | 4'-f | 1 |
| 25 | 4-oha | 1 |
| 26 | 40-bpm | 2 |
| 27 | 5.22e-15 | 1 |
| 28 | 5.39°c | 1 |
| 29 | 5fu-cisplatin | 1 |
| 30 | abca3 | 1 |
| 31 | ac-devd-cmk-pretreated | 1 |
| 32 | acvr2a/acvr2b | 1 |
| 33 | adjusted/clustered | 3 |
| 34 | adventageous | 1 |
| 35 | aedemas | 1 |
| 36 | africa-wide | 1 |
| 37 | ag110 | 1 |
| 38 | agronomists | 1 |
| 39 | alkaline- | 1 |
| 40 | all.it | 1 |
| 41 | aluminophosphates | 1 |
| 42 | amenorrhoe | 1 |
| 43 | amino-cerv | 2 |
| 44 | anti-perk1/2 | 1 |
| 45 | anti-rage-antibody | 1 |
| 46 | antioedematogenic | 1 |
| 47 | antispychotic | 1 |
| 48 | aorto-profundal | 1 |
| 49 | aponea | 1 |
| 50 | arcuatum | 1 |
| 51 | arsonists | 1 |
| 52 | asdas-levels | 1 |
| 53 | assessed.discover | 1 |
| 54 | associated-directly | 1 |
| 55 | atfd1 | 1 |
| 56 | auc0-tn | 1 |
| 57 | backgroundpubic | 1 |
| 58 | balloon/stent | 1 |
| 59 | bbr3464 | 1 |
| 60 | behavioral-risk | 2 |
| 61 | beyoglu | 1 |
| 62 | bi-specificity | 1 |
| 63 | bio-slurry | 1 |
| 64 | breast-feeding.there | 1 |
| 65 | brief-clinician | 1 |
| 66 | bright-white | 2 |
| 67 | ca15-3/br27-29 | 1 |
| 68 | canula | 1 |
| 69 | cd+se | 1 |
| 70 | cellular- | 1 |
| 71 | cephuroxime | 1 |
| 72 | cerumol® | 1 |
| 73 | cervical- | 1 |
| 74 | cetero | 1 |
| 75 | chictr-trc-00000029 | 1 |
| 76 | chondroitin-6-sulphate | 1 |
| 77 | ciclovía | 1 |
| 78 | cimp- | 1 |
| 79 | cisnet-erspc-plco | 1 |
| 80 | condition- | 1 |
| 81 | consumer- | 1 |
| 82 | cp-rate | 1 |
| 83 | crt/rt | 1 |
| 84 | ct-thorax | 1 |
| 85 | custom-trays | 1 |
| 86 | cycloheximide- | 1 |
| 87 | cyclophosphamide/doxorubicin/vincristine | 1 |
| 88 | cytoplasty | 1 |
| 89 | d212 | 1 |
| 90 | dcr-1 | 1 |
| 91 | definite/definite | 1 |
| 92 | deoxymannojirimycin | 1 |
| 93 | depth-of-interaction | 1 |
| 94 | discussed.meta-analysis | 1 |
| 95 | disreputed-so | 1 |
| 96 | dj-catheter | 1 |
| 97 | dsba-mdmt2 | 1 |
| 98 | early.more | 1 |
| 99 | ehe- | 1 |
| 100 | ejcs | 1 |
| 101 | electrocardiographical | 1 |
| 102 | embryoglue | 2 |
| 103 | endomorphic | 1 |
| 104 | ent- | 1 |
| 105 | entomophobia | 1 |
| 106 | epididimis | 1 |
| 107 | epigastrial | 1 |
| 108 | epoetin-omega | 2 |
| 109 | erythremia | 1 |
| 110 | essential.this | 1 |
| 111 | estropipate | 2 |
| 112 | etomidate-lipuro | 1 |
| 113 | eu/dy | 1 |
| 114 | exatecan | 1 |
| 115 | excitation-coupled | 1 |
| 116 | exercise-induce | 1 |
| 117 | expensive-treatments | 1 |
| 118 | feedback/tailored | 1 |
| 119 | fibrillins | 1 |
| 120 | fl.there | 1 |
| 121 | fluoropirimidines | 1 |
| 122 | flurosemide | 1 |
| 123 | forward-lunge | 2 |
| 124 | fracture- | 1 |
| 125 | fresubin®.there | 1 |
| 126 | g12c | 1 |
| 127 | g79a/f261w | 1 |
| 128 | gatiflixacin | 1 |
| 129 | gemcitabine-ifosfamide-cisplatin | 1 |
| 130 | genifuranal | 4 |
| 131 | ghia | 1 |
| 132 | glycopeptide-susceptible | 1 |
| 133 | grade3 | 1 |
| 134 | gs-π | 1 |
| 135 | gαi1 | 1 |
| 136 | gαi1-rgs12 | 1 |
| 137 | ha1a | 1 |
| 138 | hbe/β-thalassemia | 1 |
| 139 | hbv-as04 | 1 |
| 140 | hcv-infection | 1 |
| 141 | heighted | 1 |
| 142 | height²/impedance | 1 |
| 143 | hemiarthoplasty | 1 |
| 144 | hepatic-lipoprotein | 1 |
| 145 | hipokinesia | 1 |
| 146 | holdfast | 3 |
| 147 | hospitalization* | 1 |
| 148 | hpv-6/11/16 | 1 |
| 149 | huasi | 5 |
| 150 | humanmilk | 1 |
| 151 | hydroquinone/arbutin | 1 |
| 152 | hypophenomena | 1 |
| 153 | i608 | 1 |
| 154 | identified.diagnosis | 1 |
| 155 | iia+iic | 1 |
| 156 | imt+rygb | 1 |
| 157 | insecticidal/acaricidal | 1 |
| 158 | intercostovertebral | 1 |
| 159 | intratechally | 1 |
| 160 | irak-1/4 | 1 |
| 161 | juzentaiho-to | 1 |
| 162 | k216a/v219a/p222a | 1 |
| 163 | l-propranolol- | 2 |
| 164 | la/s | 1 |
| 165 | lacking.this | 1 |
| 166 | lard1 | 1 |
| 167 | lf-omega-3 | 1 |
| 168 | lillehie-kaster | 1 |
| 169 | limited.there | 1 |
| 170 | lip-service | 1 |
| 171 | lipo-lymphedema | 1 |
| 172 | lipoplex/virus | 1 |
| 173 | little | 11,688 |
| 174 | lmk03 | 1 |
| 175 | local-to-local | 1 |
| 176 | low-consistency | 1 |
| 177 | lsf- | 1 |
| 178 | lys48- | 1 |
| 179 | maintained.it | 1 |
| 180 | makgome | 1 |
| 181 | mal-positions | 1 |
| 182 | mal-rotated | 1 |
| 183 | mallotoxin | 1 |
| 184 | malnet- | 1 |
| 185 | mambey | 1 |
| 186 | mandarin- | 1 |
| 187 | manno-arabinogalacturonan | 1 |
| 188 | maturate | 1 |
| 189 | md/msc | 1 |
| 190 | meatostomy | 1 |
| 191 | med15 | 1 |
| 192 | medicament.this | 1 |
| 193 | mediterranean’ | 1 |
| 194 | menstrual/reproductive | 1 |
| 195 | metaanalysis- | 1 |
| 196 | methotrexate/dmard | 1 |
| 197 | metimazole | 1 |
| 198 | mg-l-asp | 1 |
| 199 | mi/ua | 1 |
| 200 | micro-calcifications | 2 |
| 201 | microinsurance | 1 |
| 202 | midpotent | 1 |
| 203 | mis-directed | 1 |
| 204 | model-algorithm | 1 |
| 205 | modified- | 1 |
| 206 | monoplus® | 1 |
| 207 | monosulfated | 1 |
| 208 | multi-bioactivities | 1 |
| 209 | multi-targe | 1 |
| 210 | musicure | 1 |
| 211 | myelomenigoceles | 1 |
| 212 | mykosert | 1 |
| 213 | myopenia | 1 |
| 214 | nagging/arguing | 1 |
| 215 | needed.there | 1 |
| 216 | niitaka-yomogi | 1 |
| 217 | non-diagnosed | 1 |
| 218 | non-english- | 1 |
| 219 | non-retrieved | 1 |
| 220 | non-smoke | 1 |
| 221 | non-study-related | 1 |
| 222 | non-t-cell | 1 |
| 223 | notch1- | 1 |
| 224 | nozul-al-maa | 1 |
| 225 | npc1-deficiency | 2 |
| 226 | ny-based | 1 |
| 227 | obfuscates | 1 |
| 228 | ondansetron/saline | 1 |
| 229 | orally- | 1 |
| 230 | ototopicals | 1 |
| 231 | out-of-class | 1 |
| 232 | overaeration | 1 |
| 233 | overnight- | 1 |
| 234 | overprogramming | 1 |
| 235 | pa-wei-ti-huang-wan | 2 |
| 236 | palm- | 1 |
| 237 | palosuran | 3 |
| 238 | paludrine | 1 |
| 239 | panic- | 1 |
| 240 | papaveretum-hyoscine | 1 |
| 241 | patient-volunteered | 1 |
| 242 | pedi-cap | 1 |
| 243 | pef-variability | 1 |
| 244 | peg-ifnα2a/rbv | 1 |
| 245 | penicillin/streptomycin | 1 |
| 246 | perchlorato | 1 |
| 247 | peritonization | 2 |
| 248 | ph5.7-aw0.98 | 1 |
| 249 | pharmacist- | 1 |
| 250 | pifithrin-α- | 1 |
| 251 | pneumatocele | 1 |
| 252 | pneumo- | 1 |
| 253 | pop2 | 2 |
| 254 | positioning/containment | 1 |
| 255 | post-ercc | 1 |
| 256 | post-fume | 1 |
| 257 | potorolepis | 3 |
| 258 | ppod | 1 |
| 259 | prednisone- | 1 |
| 260 | prelatent | 1 |
| 261 | prescribed-that | 1 |
| 262 | prewhitened | 1 |
| 263 | printmaking | 1 |
| 264 | pro-st | 1 |
| 265 | prolective | 1 |
| 266 | promoiety | 1 |
| 267 | proparasympathetic | 1 |
| 268 | prope | 1 |
| 269 | prorocentroids | 1 |
| 270 | proteotoxins | 1 |
| 271 | pyrimethamine-sulphadoxine | 1 |
| 272 | pyrrolidinoindolines | 1 |
| 273 | qol-form | 1 |
| 274 | quadri-therapy | 1 |
| 275 | r/k-x-x-v/p-x-x-p | 1 |
| 276 | rbr- | 1 |
| 277 | rect* | 1 |
| 278 | reeducative | 1 |
| 279 | reevacuation | 1 |
| 280 | reinstated-context | 1 |
| 281 | relapsed/progressed | 1 |
| 282 | renounced | 1 |
| 283 | rhadbomyolysis | 1 |
| 284 | rix4414+ipv | 1 |
| 285 | rs17861094 | 1 |
| 286 | sacculation | 1 |
| 287 | safrol | 2 |
| 288 | sangstat | 1 |
| 289 | saponinss | 1 |
| 290 | scophthalmi | 1 |
| 291 | secondary-transmission-of-resistance | 1 |
| 292 | seconday | 1 |
| 293 | self-disclosing | 1 |
| 294 | semi-bent | 1 |
| 295 | semi-conductive | 1 |
| 296 | semilateral | 1 |
| 297 | senkyu-cha-chosan | 1 |
| 298 | sillok | 2 |
| 299 | simulacrum | 1 |
| 300 | sinusotomy/sinectomy | 1 |
| 301 | sirna- | 1 |
| 302 | smmeox/mcm-41 | 1 |
| 303 | smooth-bounded | 1 |
| 304 | sodb-d | 1 |
| 305 | somatic-evoked | 1 |
| 306 | sono-hysterography | 1 |
| 307 | sphere- | 1 |
| 308 | square-plane | 1 |
| 309 | stop- | 1 |
| 310 | sub-pleural | 1 |
| 311 | subglobular | 1 |
| 312 | sulphinylmethyl | 1 |
| 313 | supratentorially | 1 |
| 314 | sympatholytic* | 4 |
| 315 | sympyomatic | 1 |
| 316 | syndrome/disorder | 1 |
| 317 | synovial- | 1 |
| 318 | taxative | 1 |
| 319 | tbuli | 1 |
| 320 | tele-medicine | 2 |
| 321 | teratocarcinomas | 1 |
| 322 | testiculus | 1 |
| 323 | tetrahydropyrazinopyrimidinediones | 1 |
| 324 | theorectical | 2 |
| 325 | thia- | 1 |
| 326 | thiazolidine-diones | 1 |
| 327 | thin-weak | 1 |
| 328 | thornhill | 1 |
| 329 | tienopyridines | 1 |
| 330 | tinidazol | 1 |
| 331 | touji | 2 |
| 332 | tp- | 1 |
| 333 | treatment-that | 1 |
| 334 | trial-funded | 1 |
| 335 | triplegic | 1 |
| 336 | tumor-free-resection | 1 |
| 337 | type-ii-diabetes | 1 |
| 338 | ukall97/01 | 1 |
| 339 | ultrafiltration-induced | 5 |
| 340 | umthakathi | 1 |
| 341 | un-spiked | 1 |
| 342 | unclear.this | 2 |
| 343 | unconfounded-that | 1 |
| 344 | underexpanded | 1 |
| 345 | uneconomic | 1 |
| 346 | unskillful | 1 |
| 347 | unsuccessfull | 1 |
| 348 | unsufficient | 1 |
| 349 | ureterocystoplasty | 2 |
| 350 | ureteropyelic | 1 |
| 351 | urolithasis | 1 |
| 352 | v219a/p222a | 1 |
| 353 | valdoxen | 2 |
| 354 | vasopastic | 1 |
| 355 | vgkc-complex | 1 |
| 356 | vim- | 1 |
| 357 | virally-mediated | 1 |
| 358 | wasm | 1 |
| 359 | wave2-arp2/3 | 4 |
| 360 | wish-fulfillment | 1 |
| 361 | wittingly | 1 |
| 362 | yeast- | 1 |
| 363 | zomepirac | 1 |
| 364 | β-cat/armadillo | 1 |
| 365 | σ11 | 1 |
| 366 | ϰα | 1 |
| 367 | €70,180 | 2 |
| 368 | ≥2- | 1 |
| 369 | ≥6.7mg/dl | 1 |
| 1 | sympatholytic* | 4 |
| 2 | hospitalization* | 1 |
| 3 | rect* | 1 |
| 4 | 10/40- | 1 |
| 5 | notch1- | 1 |
| 6 | ≥2- | 1 |
| 7 | lys48- | 1 |
| 8 | thia- | 1 |
| 9 | sirna- | 1 |
| 10 | panic- | 1 |
| 11 | modified- | 1 |
| 12 | cycloheximide- | 1 |
| 13 | ehe- | 1 |
| 14 | alkaline- | 1 |
| 15 | prednisone- | 1 |
| 16 | sphere- | 1 |
| 17 | fracture- | 1 |
| 18 | lsf- | 1 |
| 19 | non-english- | 1 |
| 20 | 1,6-di- | 1 |
| 21 | cervical- | 1 |
| 22 | synovial- | 1 |
| 23 | l-propranolol- | 2 |
| 24 | 2-/5-methyl- | 1 |
| 25 | vim- | 1 |
| 26 | palm- | 1 |
| 27 | mandarin- | 1 |
| 28 | condition- | 1 |
| 29 | pneumo- | 1 |
| 30 | cimp- | 1 |
| 31 | stop- | 1 |
| 32 | tp- | 1 |
| 33 | cellular- | 1 |
| 34 | rbr- | 1 |
| 35 | consumer- | 1 |
| 36 | metaanalysis- | 1 |
| 37 | malnet- | 1 |
| 38 | overnight- | 1 |
| 39 | ent- | 1 |
| 40 | yeast- | 1 |
| 41 | pharmacist- | 1 |
| 42 | orally- | 1 |
| 43 | pifithrin-α- | 1 |
| 44 | ag110 | 1 |
| 45 | 2.8e-30 | 1 |
| 46 | €70,180 | 2 |
| 47 | dcr-1 | 1 |
| 48 | ukall97/01 | 1 |
| 49 | σ11 | 1 |
| 50 | smmeox/mcm-41 | 1 |
| 51 | atfd1 | 1 |
| 52 | lard1 | 1 |
| 53 | gαi1 | 1 |
| 54 | anti-perk1/2 | 1 |
| 55 | d212 | 1 |
| 56 | gαi1-rgs12 | 1 |
| 57 | pop2 | 2 |
| 58 | dsba-mdmt2 | 1 |
| 59 | lf-omega-3 | 1 |
| 60 | wave2-arp2/3 | 4 |
| 61 | lmk03 | 1 |
| 62 | abca3 | 1 |
| 63 | grade3 | 1 |
| 64 | irak-1/4 | 1 |
| 65 | hbv-as04 | 1 |
| 66 | bbr3464 | 1 |
| 67 | rs17861094 | 1 |
| 68 | 5.22e-15 | 1 |
| 69 | 215.15 | 1 |
| 70 | med15 | 1 |
| 71 | hpv-6/11/16 | 1 |
| 72 | i608 | 1 |
| 73 | 1979-88 | 1 |
| 74 | ph5.7-aw0.98 | 1 |
| 75 | ca15-3/br27-29 | 1 |
| 76 | chictr-trc-00000029 | 1 |
| 77 | ha1a | 1 |
| 78 | v219a/p222a | 1 |
| 79 | k216a/v219a/p222a | 1 |
| 80 | nozul-al-maa | 1 |
| 81 | aponea | 1 |
| 82 | epoetin-omega | 2 |
| 83 | 4-oha | 1 |
| 84 | entomophobia | 1 |
| 85 | ghia | 1 |
| 86 | erythremia | 1 |
| 87 | hbe/β-thalassemia | 1 |
| 88 | myopenia | 1 |
| 89 | hipokinesia | 1 |
| 90 | 'tia | 1 |
| 91 | canula | 1 |
| 92 | lipo-lymphedema | 1 |
| 93 | hypophenomena | 1 |
| 94 | mi/ua | 1 |
| 95 | ciclovía | 1 |
| 96 | acvr2a/acvr2b | 1 |
| 97 | imt+rygb | 1 |
| 98 | g12c | 1 |
| 99 | zomepirac | 1 |
| 100 | post-ercc | 1 |
| 101 | backgroundpubic | 1 |
| 102 | triplegic | 1 |
| 103 | endomorphic | 1 |
| 104 | iia+iic | 1 |
| 105 | ureteropyelic | 1 |
| 106 | uneconomic | 1 |
| 107 | antioedematogenic | 1 |
| 108 | sympyomatic | 1 |
| 109 | proparasympathetic | 1 |
| 110 | antispychotic | 1 |
| 111 | vasopastic | 1 |
| 112 | md/msc | 1 |
| 113 | 150-160°c | 1 |
| 114 | 5.39°c | 1 |
| 115 | sodb-d | 1 |
| 116 | renounced | 1 |
| 117 | ultrafiltration-induced | 5 |
| 118 | underexpanded | 1 |
| 119 | trial-funded | 1 |
| 120 | smooth-bounded | 1 |
| 121 | un-spiked | 1 |
| 122 | somatic-evoked | 1 |
| 123 | excitation-coupled | 1 |
| 124 | prewhitened | 1 |
| 125 | patient-volunteered | 1 |
| 126 | adjusted/clustered | 3 |
| 127 | feedback/tailored | 1 |
| 128 | ny-based | 1 |
| 129 | non-diagnosed | 1 |
| 130 | relapsed/progressed | 1 |
| 131 | ac-devd-cmk-pretreated | 1 |
| 132 | monosulfated | 1 |
| 133 | virally-mediated | 1 |
| 134 | non-study-related | 1 |
| 135 | mal-rotated | 1 |
| 136 | mis-directed | 1 |
| 137 | heighted | 1 |
| 138 | non-retrieved | 1 |
| 139 | ppod | 1 |
| 140 | methotrexate/dmard | 1 |
| 141 | lip-service | 1 |
| 142 | height²/impedance | 1 |
| 143 | microinsurance | 1 |
| 144 | secondary-transmission-of-resistance | 1 |
| 145 | exercise-induce | 1 |
| 146 | 2-cyanoacetamide | 1 |
| 147 | 1-h-indole-3-glyoxamide | 1 |
| 148 | flurosemide | 1 |
| 149 | africa-wide | 1 |
| 150 | forward-lunge | 2 |
| 151 | multi-targe | 1 |
| 152 | 0.024.the | 1 |
| 153 | non-smoke | 1 |
| 154 | glycopeptide-susceptible | 1 |
| 155 | pneumatocele | 1 |
| 156 | metimazole | 1 |
| 157 | little | 11,688 |
| 158 | cephuroxime | 1 |
| 159 | makgome | 1 |
| 160 | post-fume | 1 |
| 161 | square-plane | 1 |
| 162 | tele-medicine | 2 |
| 163 | papaveretum-hyoscine | 1 |
| 164 | ondansetron/saline | 1 |
| 165 | paludrine | 1 |
| 166 | cyclophosphamide/doxorubicin/vincristine | 1 |
| 167 | pyrimethamine-sulphadoxine | 1 |
| 168 | amenorrhoe | 1 |
| 169 | prope | 1 |
| 170 | 0.079.there | 1 |
| 171 | needed.there | 1 |
| 172 | limited.there | 1 |
| 173 | breast-feeding.there | 1 |
| 174 | fl.there | 1 |
| 175 | fresubin®.there | 1 |
| 176 | early.more | 1 |
| 177 | musicure | 1 |
| 178 | cd+se | 1 |
| 179 | chondroitin-6-sulphate | 1 |
| 180 | estropipate | 2 |
| 181 | cp-rate | 1 |
| 182 | maturate | 1 |
| 183 | 3-amino-isobutyrate | 1 |
| 184 | bright-white | 2 |
| 185 | definite/definite | 1 |
| 186 | embryoglue | 2 |
| 187 | reeducative | 1 |
| 188 | taxative | 1 |
| 189 | prolective | 1 |
| 190 | semi-conductive | 1 |
| 191 | menstrual/reproductive | 1 |
| 192 | 4'-f | 1 |
| 193 | 10-15mmhg | 1 |
| 194 | 19-mg | 1 |
| 195 | 'something | 2 |
| 196 | printmaking | 1 |
| 197 | overprogramming | 1 |
| 198 | self-disclosing | 1 |
| 199 | nagging/arguing | 1 |
| 200 | niitaka-yomogi | 1 |
| 201 | umthakathi | 1 |
| 202 | touji | 2 |
| 203 | tbuli | 1 |
| 204 | scophthalmi | 1 |
| 205 | huasi | 5 |
| 206 | thin-weak | 1 |
| 207 | humanmilk | 1 |
| 208 | sillok | 2 |
| 209 | behavioral-risk | 2 |
| 210 | 1,2u/l | 1 |
| 211 | electrocardiographical | 1 |
| 212 | theorectical | 2 |
| 213 | local-to-local | 1 |
| 214 | insecticidal/acaricidal | 1 |
| 215 | aorto-profundal | 1 |
| 216 | epigastrial | 1 |
| 217 | genifuranal | 4 |
| 218 | intercostovertebral | 1 |
| 219 | semilateral | 1 |
| 220 | sub-pleural | 1 |
| 221 | ≥6.7mg/dl | 1 |
| 222 | non-t-cell | 1 |
| 223 | thornhill | 1 |
| 224 | unsuccessfull | 1 |
| 225 | safrol | 2 |
| 226 | tinidazol | 1 |
| 227 | unskillful | 1 |
| 228 | sulphinylmethyl | 1 |
| 229 | 3-succinoyl-4,5-dicaffeoyl | 1 |
| 230 | 'ram | 1 |
| 231 | model-algorithm | 1 |
| 232 | 40-bpm | 2 |
| 233 | qol-form | 1 |
| 234 | wasm | 1 |
| 235 | 'polymorphism | 1 |
| 236 | 186-rhenium | 1 |
| 237 | simulacrum | 1 |
| 238 | arcuatum | 1 |
| 239 | exatecan | 1 |
| 240 | brief-clinician | 1 |
| 241 | manno-arabinogalacturonan | 1 |
| 242 | palosuran | 3 |
| 243 | senkyu-cha-chosan | 1 |
| 244 | pa-wei-ti-huang-wan | 2 |
| 245 | valdoxen | 2 |
| 246 | gatiflixacin | 1 |
| 247 | deoxymannojirimycin | 1 |
| 248 | penicillin/streptomycin | 1 |
| 249 | hepatic-lipoprotein | 1 |
| 250 | gemcitabine-ifosfamide-cisplatin | 1 |
| 251 | 5fu-cisplatin | 1 |
| 252 | hydroquinone/arbutin | 1 |
| 253 | mallotoxin | 1 |
| 254 | sacculation | 1 |
| 255 | overaeration | 1 |
| 256 | 1,2,4,15-configuration | 1 |
| 257 | reevacuation | 1 |
| 258 | peritonization | 2 |
| 259 | depth-of-interaction | 1 |
| 260 | hcv-infection | 1 |
| 261 | tumor-free-resection | 1 |
| 262 | auc0-tn | 1 |
| 263 | cisnet-erspc-plco | 1 |
| 264 | β-cat/armadillo | 1 |
| 265 | cetero | 1 |
| 266 | etomidate-lipuro | 1 |
| 267 | disreputed-so | 1 |
| 268 | juzentaiho-to | 1 |
| 269 | perchlorato | 1 |
| 270 | r/k-x-x-v/p-x-x-p | 1 |
| 271 | pedi-cap | 1 |
| 272 | mg-l-asp | 1 |
| 273 | subglobular | 1 |
| 274 | syndrome/disorder | 1 |
| 275 | dj-catheter | 1 |
| 276 | lillehie-kaster | 1 |
| 277 | assessed.discover | 1 |
| 278 | la/s | 1 |
| 279 | aedemas | 1 |
| 280 | teratocarcinomas | 1 |
| 281 | ejcs | 1 |
| 282 | prorocentroids | 1 |
| 283 | 2'-arylthio-3,3'-bithiophene-2-carbaldehydes | 1 |
| 284 | multi-bioactivities | 1 |
| 285 | myelomenigoceles | 1 |
| 286 | fluoropirimidines | 1 |
| 287 | tienopyridines | 1 |
| 288 | pyrrolidinoindolines | 1 |
| 289 | thiazolidine-diones | 1 |
| 290 | tetrahydropyrazinopyrimidinediones | 1 |
| 291 | obfuscates | 1 |
| 292 | aluminophosphates | 1 |
| 293 | type-ii-diabetes | 1 |
| 294 | lacking.this | 1 |
| 295 | essential.this | 1 |
| 296 | unclear.this | 2 |
| 297 | medicament.this | 1 |
| 298 | epididimis | 1 |
| 299 | potorolepis | 3 |
| 300 | urolithasis | 1 |
| 301 | identified.diagnosis | 1 |
| 302 | discussed.meta-analysis | 1 |
| 303 | rhadbomyolysis | 1 |
| 304 | ototopicals | 1 |
| 305 | asdas-levels | 1 |
| 306 | fibrillins | 1 |
| 307 | proteotoxins | 1 |
| 308 | micro-calcifications | 2 |
| 309 | mal-positions | 1 |
| 310 | out-of-class | 1 |
| 311 | saponinss | 1 |
| 312 | expensive-treatments | 1 |
| 313 | agronomists | 1 |
| 314 | arsonists | 1 |
| 315 | testiculus | 1 |
| 316 | adventageous | 1 |
| 317 | lipoplex/virus | 1 |
| 318 | custom-trays | 1 |
| 319 | prescribed-that | 1 |
| 320 | unconfounded-that | 1 |
| 321 | treatment-that | 1 |
| 322 | sangstat | 1 |
| 323 | maintained.it | 1 |
| 324 | all.it | 1 |
| 325 | semi-bent | 1 |
| 326 | unsufficient | 1 |
| 327 | wish-fulfillment | 1 |
| 328 | positioning/containment | 1 |
| 329 | prelatent | 1 |
| 330 | midpotent | 1 |
| 331 | balloon/stent | 1 |
| 332 | crt/rt | 1 |
| 333 | mykosert | 1 |
| 334 | pro-st | 1 |
| 335 | holdfast | 3 |
| 336 | reinstated-context | 1 |
| 337 | beyoglu | 1 |
| 338 | peg-ifnα2a/rbv | 1 |
| 339 | rix4414+ipv | 1 |
| 340 | amino-cerv | 2 |
| 341 | g79a/f261w | 1 |
| 342 | ct-thorax | 1 |
| 343 | vgkc-complex | 1 |
| 344 | seconday | 1 |
| 345 | npc1-deficiency | 2 |
| 346 | low-consistency | 1 |
| 347 | eu/dy | 1 |
| 348 | anti-rage-antibody | 1 |
| 349 | mambey | 1 |
| 350 | sono-hysterography | 1 |
| 351 | wittingly | 1 |
| 352 | intratechally | 1 |
| 353 | supratentorially | 1 |
| 354 | associated-directly | 1 |
| 355 | sinusotomy/sinectomy | 1 |
| 356 | meatostomy | 1 |
| 357 | quadri-therapy | 1 |
| 358 | bio-slurry | 1 |
| 359 | promoiety | 1 |
| 360 | bi-specificity | 1 |
| 361 | pef-variability | 1 |
| 362 | hemiarthoplasty | 1 |
| 363 | ureterocystoplasty | 2 |
| 364 | cytoplasty | 1 |
| 365 | gs-π | 1 |
| 366 | mediterranean’ | 1 |
| 367 | cerumol® | 1 |
| 368 | monoplus® | 1 |
| 369 | ϰα | 1 |